Last updated on August 2018

Survey Study for Velaglucerase Alfa (VPRIV) in Japan


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Gaucher Disease
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Male or female participants with a confirmed diagnosis of Gaucher disease
  • Participants who are either nave to treatment or participants that have been treated with another therapeutic agent for Gaucher disease
  • Participants who start VPRIV treatment or transition from VPRIV clinical studies during the enrollment period

Exclusion Criteria:

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.